Article Text

Download PDFPDF
EU news
The European coalition for vaccination calls on healthcare professionals to get vaccinated against COVID-19
  1. Stephanie Kohl
  1. Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium
  1. Correspondence to Stephanie Kohl, Policy & Advocacy, European Association of Hospital Pharmacists, Brussels 1200, Belgium; Stephanie.Kohl{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In February 2021, the Coalition for Vaccination has published a manifesto to encourage healthcare professionals to get vaccinated against COVID-19.

The manifesto highlights three key reasons why all healthcare professionals should get vaccinated against COVID-19 when they have the opportunity to do so and why they should help promote the vaccination against COVID-19 among the general public.

  1. You protect yourself from illness and possible severe or life-threatening complications

  2. COVID-19 vaccines are safe and effective

  3. You help safeguard healthcare capacity

The Coalition for Vaccination brings together European associations of healthcare professionals and relevant students’ associations in the field, as well as associated professional organisations working in the field of public health and immunisation. It was convened by the European Commission in 2019 to deliver accurate information to the public, to combat myths and to exchange best practices. The Coalition is co-led by the Standing Committee of European Doctors (CPME), the European Federation of Nurses Associations (EFN) and the Pharmaceutical Group of the European Union (PGEU).

Updates from the European Medicines Agency

The European Medicines Agency (EMA) published a direct to healthcare professional communication for Vaxzevria (previously COVID-19 Vaccine AstraZeneca), a plain-language description of medical terms related to medicines use and communications advising against the use of ivermectin for the prevention or treatment of COVID-19 outside randomised clinical trials and on the precautionary marketing suspension of the thalassaemia medicine Zynteglo.

COVID-19 vaccine AstraZeneca – direct healthcare professional communication

EMA has released a direct healthcare professional communication (DHPC) on the risk of thrombocytopenia and coagulation disorders with the COVID-19 Vaccine AstraZeneca. It contains important information for healthcare professionals prescribing, dispensing or administering this vaccine. As noted in the DHPC:

  • Benefits of the COVID-19 Vaccine AstraZeneca outweigh the risks despite the possible link to very rare blood clots with low blood platelets.

  • A combination of thrombosis and thrombocytopenia, in some cases accompanied by bleeding, has been observed very …

View Full Text


  • Competing interests None declared.

  • Provenance and peer review Commissioned; internally peer reviewed.